360 related articles for article (PubMed ID: 37382486)
1. A new era for myelin research in Neurofibromatosis type 1.
de Blank P; Nishiyama A; López-Juárez A
Glia; 2023 Dec; 71(12):2701-2719. PubMed ID: 37382486
[TBL] [Abstract][Full Text] [Related]
2. Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.
Hernandez DP; Cruz DM; Martinez CS; Garcia LM; Figueroa A; Villarreal M; Manoj LM; Lopez S; López-Lorenzo KD; López-Juárez A
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339230
[TBL] [Abstract][Full Text] [Related]
3. An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.
Smith TF; Kaczorowski JA; Acosta MT
Childs Nerv Syst; 2020 Oct; 36(10):2321-2332. PubMed ID: 32617712
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis.
Johnson MR; Ferner RE; Bobrow M; Hughes RA
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):643-6. PubMed ID: 10766898
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.
López-Juárez A; Titus HE; Silbak SH; Pressler JW; Rizvi TA; Bogard M; Bennett MR; Ciraolo G; Williams MT; Vorhees CV; Ratner N
Cell Rep; 2017 Apr; 19(3):545-557. PubMed ID: 28423318
[TBL] [Abstract][Full Text] [Related]
6. White matter is increased in the brains of adults with neurofibromatosis 1.
Wang S; Friedman JM; Suppa P; Buchert R; Mautner VF
Orphanet J Rare Dis; 2022 Mar; 17(1):115. PubMed ID: 35248131
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular mechanisms of learning disabilities: a focus on NF1.
Shilyansky C; Lee YS; Silva AJ
Annu Rev Neurosci; 2010; 33():221-43. PubMed ID: 20345245
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.
Kaczorowski JA; Smith TF; Shrewsbury AM; Thomas LR; Knopik VS; Acosta MT
Behav Genet; 2020 Jul; 50(4):191-202. PubMed ID: 32026187
[TBL] [Abstract][Full Text] [Related]
9. Brain-wide structural and functional disruption in mice with oligodendrocyte-specific
Asleh J; Shofty B; Cohen N; Kavushansky A; López-Juárez A; Constantini S; Ratner N; Kahn I
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22506-22513. PubMed ID: 32839340
[TBL] [Abstract][Full Text] [Related]
10. Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.
Maloney SE; Chandler KC; Anastasaki C; Rieger MA; Gutmann DH; Dougherty JD
Autism Res; 2018 Jan; 11(1):44-58. PubMed ID: 28842941
[TBL] [Abstract][Full Text] [Related]
11. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
[TBL] [Abstract][Full Text] [Related]
12. Reduced higher dimensional temporal dynamism in neurofibromatosis type 1.
Mennigen E; Schuette P; Vajdi A; Pacheco L; Rosser T; Bearden CE
Neuroimage Clin; 2019; 22():101692. PubMed ID: 30710873
[TBL] [Abstract][Full Text] [Related]
13. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
Amato A; Imbimbo BP; Falsini B
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
[TBL] [Abstract][Full Text] [Related]
15. The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.
Acosta MT; Bearden CE; Castellanos FX; Cutting L; Elgersma Y; Gioia G; Gutmann DH; Lee YS; Legius E; Muenke M; North K; Parada LF; Ratner N; Hunter-Schaedle K; Silva AJ
Am J Med Genet A; 2012 Sep; 158A(9):2225-32. PubMed ID: 22821737
[TBL] [Abstract][Full Text] [Related]
16. Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.
Castricum J; Tulen JHM; Taal W; Rietman AB; Elgersma Y
J Atten Disord; 2022 Feb; 26(4):563-572. PubMed ID: 33978520
[TBL] [Abstract][Full Text] [Related]
17. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms.
Molosh AI; Shekhar A
Prog Brain Res; 2018; 241():37-62. PubMed ID: 30447756
[TBL] [Abstract][Full Text] [Related]
20. Alterations in white matter microstructure in neurofibromatosis-1.
Karlsgodt KH; Rosser T; Lutkenhoff ES; Cannon TD; Silva A; Bearden CE
PLoS One; 2012; 7(10):e47854. PubMed ID: 23094098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
